DNADX

Owners

Goods & Services

Diagnostic preparations for medical purposes, in the field of cancer; diagnostic reagents for medical use, in the field of cancer; diagnostic biomarker reagents for medical purposes, in the field of cancer; clinical medical reagents, in the field of cancer; medical diagnostic reagents for use in analysis of circulating tumor DNA extracted from blood samples, for use in the field of cancer; medical diagnostic reagents for use in diagnostic tests, in the field of cancer; biomarkers being copy number alterations and gene mutation for the diagnosis, prognosis and treatment of cancer; medical diagnostic reagents and assays for the diagnosis, prognosis and treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; compounds, namely, chemotherapy drugs, inmunotherapy agents, targeted drug therapies and hormonal therapies for treating cancer; pharmaceutical preparations for use in oncology; biological reagents for medical use, in the field of cancer; diagnostic reagent kits comprised of medical diagnostic reagents and assays for testing body fluids for medical use in the field of cancer.

Diagnostic preparations for scientific purposes, in the field of cancer; reagents for research purposes, in the field of cancer; reagents for medical research, in the field of cancer; diagnostic reagents for scientific or research use, in the field of cancer; reagents for scientific or research use in the field of cancer; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, in the field of cancer